Adherence to HIV Regimens: Research

DO. SEE. HEAR. KNOW. Visit TheBody.com's 2008 World AIDS Day Center >>

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

Show Archived (Historical) Articles

Researchers Develop Breath-Monitoring Device to Monitor Treatment Adherence Among HIV-Positive People (April 23, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Among Patients on Boosted-PI Regimens, Dose Staggering and Selective Non-Adherence to Ritonavir Is Relatively Common (February 6, 2008)
From The Body PRO
HIV-Positive People With Depression More Likely to Follow Treatment Regimens When Taking SSRIs, Study Finds (January 8, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Effects of Adherence Support Programmes May Be Short Lived (January 2, 2008)
From aidsmap.com
Consequences of Non-Adherence Worse in African-Americans Than White People (December 16, 2007)
From aidsmap.com
Adherence to HIV Treatment Linked to Health Literacy, Study Finds (November 19, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Once-Daily Nevirapine Doesn't Improve Adherence, May Increase Risk of Treatment Break and Resistance (October 26, 2007)
From aidsmap.com
Pillboxes Should Be Standard Issue for HIV Patients, Study Concludes (September 10, 2007)
From aidsmap.com
Lower Adherence May Precede Viral Load "Blips" (September 28, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
Higher Degree of Medication "Forgiveness" in Use of Boosted Protease Inhibitors (August 15, 2006)
In The XVI International AIDS Conference
HIV JournalView: Adherence, Viral Fitness and NNRTI and PI Resistance (February/March 2006)
Bangsberg et al find that NNRTIs are more likely to suppress HIV than a single PI, but are also more vulnerable to resistance at low adherence levels.
From The Body PRO
Industry-Sponsored Study Examines Factors Influencing Adherence (Winter 2005/2006)
The demands of life and work are the biggest obstacles to perfect adherence, HIVers say.
To read PDF, click here
In Body Positive, from Body Positive
Literature Review: Antidepressant Treatment Improves Adherence to Antiretrovirals (January 2006)
In Infectious Diseases in Corrections Report, from Brown Medical School
Adherence in the Developing World: It's Not Just About the Meds (December 2005)
Harvard University professor Arachu Castro discusses the roles that biology, society and poverty play in determining the adherence levels of HIV-infected people in resource-poor countries.
In PLoS Medicine
New Device Offers Friendly Medication Reminder to HIV Patients (October 12, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Couple-Focused Support Improves HIV Medication Adherence (August 24, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Use of and Adherence to Antiretroviral Therapy Is Associated With Decreased Sexual Risk Behavior in HIV Clinic Patients (August 10, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Adherence to Antiretroviral Therapy Among Substance Users (June 2005)
Guidelines from the New York State Department of Health AIDS Institute.
To read PDF, click here
From New York State Department of Health
HIV and Depression: Antidepressant Use Improves HAART Adherence (March 17, 2005)
This study finds that clinically depressed HIVers who receive antidepressants are more likely to adhere to their HIV medications.
From aidsmap.com
Is 80%-90% Adherence the Best Predictor of Drug Failure? (February/March 2005)
A study suggests that resistance risk is highest for people who have good, but not great, treatment adherence.
From The Body PRO
NNRTI Resistance Occurs More Often at Lower Levels of Adherence Than Does PI Resistance (July 14, 2004)
In The XV International AIDS Conference, from The Body PRO
Adherence Conference: Elements of Success (March/April 2004)
Highlights from the 2nd International Conference on Adherence to Antiretroviral Therapy (December 4-7, 2003).
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Adherence, not Baseline CD4 Cell Count, Linked to CD4 Cell Gain on HAART (February 25, 2004)
New support for those who feel treatment should be delayed until a patient's CD4 cell count falls near 200.
From aidsmap.com
HIV Treatment Education Program Beneficial for Adherence, Health of HAART Patients (January 23, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Adherence and HIV Drug Resistance (January 2004)
"Near-perfect" adherence to a powerful HAART regimen appears to be the best way to avoid developing drug-resistant HIV.
In Hopkins HIV Report
HAART Often Successful in HIV/HCV Coinfected Patients -- If They Can Stay on Treatment (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
HIV-Positive Brazilian Women Find Adherence Hard (September 15, 2003)
From aidsmap.com
African HIV/AIDS Patients Show Better Adherence to Antiretroviral Drug Regimens Than U.S. Counterparts (September 3, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Resistance Still Possible Despite Perfect Adherence, Study Says (August 28, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Adherence to HIV Antiretrovirals Among Persons With Serious Mental Illness (August 11, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Keys to Adherence in Youth: Simplicity, Knowledge, Support (August 7, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
U.S. Teen HIV Prevention, HAART Adherence Programs Examined (August 5, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Better Suppression, Adherence With Once-Daily FTC/ddI/Efavirenz Than Most PI-Based Regimens (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
Simplification Works! Fewer Pills Mean Better Adherence and Quality of Life (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
Doubts About DOT: Antiretroviral Therapy for Resource-Poor Countries (July 8, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
South Africa: HIV Treatment Adherence as High as Developed World (July 7, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Assessment of Changes in Adherence and Quality of Life After the Simplification of Antiretroviral Treatment (July 2003)
Highlights from the IAPAC Sessions 2003.
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care
New Initiative Aims to Increase HAART Adherence (June 25, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Study Details Link Between Attitude, Adherence (April 30, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Starting Therapy and Adherence: Moving Beyond Pill Boxes and Timers (April 28, 2003)
From Canadian AIDS Treatment Information Exchange
Relationship of Gender, Depression, and Health Care Delivery With Antiretroviral Adherence in HIV-Infected Drug Users (April 2003)
In Journal of General Internal Medicine
DAAT May Work Where DOT Model Fell Short (February 5, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Baltimore: HIV Medication -- Patients Get Someone to Watch Over Them (February 3, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Directly Administered Antiretroviral Therapy in the Treatment of HIV Infection: Benefit or Burden? (January 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Plasma Protease Inhibitor Levels Can Mark Nonadherence (January 23, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Simpler Therapy Can Help HIV Patients (December 26, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Directly-Observed Therapy in HIV-Positive Heroin Users (December 20, 2002)
From Canadian AIDS Treatment Information Exchange
Therapy Adherence and Highly Active Antiretroviral Therapy: Comparison of Three Sources of Information (December 16, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral Therapy (December 15, 2002)
In Journal of Acquired Immune Deficiency Syndromes
Perception of Punishment Undermines Adherence (November 27, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Mediators of Social Support and Antiretroviral Adherence Among an Indigent Population in New York City (November 14, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Report on Adherence From the XIV International AIDS Conference in Barcelona (November 2002)
In Hopkins HIV Report
Intentional Nonadherence to HAART Common Due to Side Effects, Study Finds (October 31, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Adherence Intervention Project Linked to Lower Viral Load (October 28, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Potential Impact of Once-Daily Regimens on Adherence to HAART (October 26, 2002)
In 40th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO
New York: HIV Patients' Drug Regimens Upset by September 11th (September 11, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Durability and Predictors of Success of Highly Active Antiretroviral Therapy for Ambulatory HIV-Infected Patients (September 10, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
DOT for HAART: Directly Observed Therapy (Fall 2002)
To read PDF, click here
In STEP Perspective, from Seattle Treatment Education Project
Internet Paging System Helps Improve Adherence (August 23, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Counseling Program Found to Benefit Newly Diagnosed HIV Patients (August 14, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Effects of Depressive Symptoms and Mental Health Quality of Life on Use of Highly Active Antiretroviral Therapy Among HIV-Seropositive Women (August 1, 2002)
In Journal of Acquired Immune Deficiency Syndromes
Adherence to HAART Has Major Impact on Survival in HIV-Infected Patients (July 23, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Adherence Research Roundup From the International AIDS Conference (July 13, 2002)
In The XIV International AIDS Conference, from The Body PRO
Highlights of Presentations on Gender From Barcelona (July 13, 2002)
Includes a review of research on women's adherence to HAART.
In The XIV International AIDS Conference, from The Body PRO
Adherence to Combivir as Post-Exposure Prophylaxis in Non-Occupational HIV Exposures (July 8, 2002)
In The XIV International AIDS Conference, from The Body PRO
Viral Blips and Virologic Failure (April 29, 2002)
Study results presented at Retrovirus 2002.
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
Selected Highlights From Retrovirus: Adherence to Therapy (February 28, 2002)
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Nevirapine and Protease Inhibitor-Based Regimens in a Directly Observed Therapy (DOT) Program for Intravenous Drug Users (February 26, 2002)
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
An Examination of Social and Behavioral Factors Potentially Affecting Black Men's Ability to Adhere to HAART (February 13, 2002)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
Simplification of Protease Inhibitor-Containing HAART Regimen With Abacavir Maintains Viral Suppression and Favorable Adherence in HIV-1 Infected Adults (October 27, 2001)
In 39th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO
Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study (September 10, 2001)
In Archives of Internal Medicine
Spotlight: Telemedicine in Clinical Practice (June/July 2001)
To read PDF, click here
In HEPP News, from Brown Medical School
A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors (May 15, 2001)
In Annals of Internal Medicine
Impact of Directly-Observed Therapy on Long-Term Outcomes in HIV Clinical Trials (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Adherence to HIV Therapy (2001)
From Forum for Collaborative HIV Research
Highlights From the XIII International AIDS Conference: Adherence and Twice-Daily Dosing (Autumn 2000)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Patient Adherence With Twice-Daily Dosing of Nelfinavir Equivalent to NNRTIs When Given in Combination With Dual NRTIs (July 13, 2000)
In The XIII International AIDS Conference, from The Body PRO
Self-Efficacy: Predictor of Adherence to Antiretroviral Medications (July 13, 2000)
In The XIII International AIDS Conference, from The Body PRO
Study of Adherence to HAART in a Sample of HIV-Infected Patients (July 13, 2000)
In The XIII International AIDS Conference, from The Body PRO
Low Frequency of Genotypic Resistance Markers in Therapy-Naive HIV+ Adolescents (July 11, 2000)
In The XIII International AIDS Conference, from The Body PRO
Poorer Adherence to HAART and Risky Sex Behavior Within HIV-Serodiscordant Couples (July 11, 2000)
In The XIII International AIDS Conference, from The Body PRO
Patient Adherence to Antiretroviral Therapies -- I (July 10, 2000)
In The XIII International AIDS Conference, from The Body PRO
Feasibility Study of the Disease Management Assistance System: A Potential Adherence Enhancement Device (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Non-Compliance Often the Cause When AIDS Drugs "Fail" (January 22, 2000)
In British Medical Journal
Taking a Break When All Else Fails (April 1999)
In GMHC Treatment Issues, from Gay Men's Health Crisis
AIDS Researchers Target Poor Adherence (March 24, 1999)
In Journal of the American Medical Association
Adherence Matters: Dose-Skipping Is Risky Business (February 1999)
In Positive Living, from AIDS Project Los Angeles
Antiretroviral Therapy: Adherence and Quality of Life (February 1, 1999)
In The 6th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Obstacles to Treatment Success (October 1998)
In GMHC Treatment Issues, from Gay Men's Health Crisis
The Perils of Discontinuing Therapy: Without HAART, Cytokines Stimulate HIV From Latently Infected Cells (July 6, 1998)
From U.S. National Institute of Allergy and Infectious Diseases
Protease Inhibitors in the HIV+ Homeless and Marginally Housed: Good Adherence but Rarely Prescribed (July 1, 1998)
In The 12th International AIDS Conference, from The Body PRO
Mutinous Rumblings of Pill Popping Public Prompts Drug Outfits' Focus on User-Friendly Dosing Schemes (June 1998)
In TAGline, from Treatment Action Group
Mechanisms of Antiretroviral Therapy Failure: Adherence (May 1, 1998)
In The 8th Clinical Care Options for HIV Symposium, from The Body PRO
Adhering to Complex Regimens for HIV (April 1998)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Adherence and the HIV Community (January 1998)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Update on Adherence to HIV Therapy (January 1998)
In Hopkins HIV Report

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.